Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpelisib + Paclitaxel in PIK3CA-altered Gastric Cancer
NCT04526470Phase 2Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpelisib in gastric cancer (GC), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
alpelisib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04526470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04526470.